EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bioinformatics of germline variant discovery for rare disease diagnostics: current approaches and remaining challenges

Yury A Barbitoff iD, Mikhail O Ushakov, Tatyana E Lazareva, Yulia A Nasykhova, Andrey S Glotov, Alexander V Predeus

Briefings in Bioinformatics · 22.01.2024 · 25 (2)

DOI: 10.1093/bib/bbad508 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, online erschienen am 23.01.2024. Verfasst von Yury A Barbitoff und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dpt. of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynaecology, and Reproductology, Mendeleevskaya line 3, 199034, St. Petersburg, …. Hauptthemen laut MEDLINE: Rare Diseases, Computational Biology. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Next-generation sequencing (NGS) has revolutionized the field of rare disease diagnostics. Whole exome and whole genome sequencing are now routinely used for diagnostic purposes; however, the overall diagnosis rate remains lower than expected. In this work, we review current approaches used for calling and interpretation of germline genetic variants in the human genome, and discuss the most important challenges that persist in the bioinformatic analysis of NGS data in medical genetics. We describe and attempt to quantitatively assess the remaining problems, such as the quality of the reference genome sequence, reproducible coverage biases, or variant calling accuracy in complex regions of the genome. We also discuss the prospects of switching to the complete human genome assembly or the human pan-genome and important caveats associated with such a switch. We touch on arguably the hardest problem of NGS data analysis for medical genomics, namely, the annotation of genetic variants and their subsequent interpretation. We highlight the most challenging aspects of annotation and prioritization of both coding and non-coding variants. Finally, we demonstrate the persistent prevalence of pathogenic variants in the coding genome, and outline research directions that may enhance the efficiency of NGS-based disease diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesComputational BiologyHumansGenomicsGenome, HumanGerm CellsHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

NGSWESreference genomevariant annotationvariant calling

Autor:innen und Institutionen

  • Dpt. of Genomic Medicine, D.O. Ott Research Institute of Obstetrics, Gynaecology, and Reproductology, Mendeleevskaya line 3, 199034, St. Petersburg, Russia.
  • Bioinformatics Institute, Kentemirovskaya st. 2A, 197342, St. Petersburg, Russia.

ORCID-Profile: Yury A Barbitoff

Förderung

  • Ministry of Science and Higher Education of Russian Federation

Zitieren

APA

Barbitoff, Y. A., Ushakov, M. O., Lazareva, T. E., Nasykhova, Y. A., Glotov, A. S., & Predeus, A. V. (2024). Bioinformatics of germline variant discovery for rare disease diagnostics: current approaches and remaining challenges. Briefings in Bioinformatics, 25(2). https://doi.org/10.1093/bib/bbad508

Vancouver

Barbitoff YA, Ushakov MO, Lazareva TE, Nasykhova YA, Glotov AS, Predeus AV. Bioinformatics of germline variant discovery for rare disease diagnostics: current approaches and remaining challenges. Briefings in Bioinformatics. 2024;25(2). doi:10.1093/bib/bbad508

BibTeX
@article{Barbitoff2024,
  author = {Barbitoff, Yury A and Ushakov, Mikhail O and Lazareva, Tatyana E and Nasykhova, Yulia A and Glotov, Andrey S and Predeus, Alexander V},
  title = {Bioinformatics of germline variant discovery for rare disease diagnostics: current approaches and remaining challenges},
  journal = {Briefings in Bioinformatics},
  year = {2024},
  volume = {25},
  number = {2},
  doi = {10.1093/bib/bbad508}
}
Kostenlos starten →